ROLE OF CONTINUOUS GLUCOSE MONITORING IN DIABETIC NEUROPATHY
Diabetes is a major health problem due to its high prevalence and chronic complications that lead to disability and reduced quality of life. Among the complications, diabetic neuropathy, with its many forms, is the most common. Glycemic control plays a crucial role in the occurrence of chronic complications. Recently, with the advent of new technologies for continuous glycemic monitoring, the role of glycemic variability in the occurrence, progression, evaluation and treatment of chronic complications is increasingly understood. The widespread use of these technologies in clinical practice will optimize the care of patients with diabetes.
 L. Ang, M. Jaiswal, C. Martin, R. Pop-Busui. Glucose control and diabetic neuropathy: lessons from recent large clinical trials. Curr Diab Rep, Vol 14, pp 528, January 2014.
 R. Pop-Busui, W.H. Herman, E.L. Feldman, P.A. Low, C.L. Martin, P.A. Cleary, et al. DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history. Curr Diab Rep; Vol 10, pp 276–282, March 2010.
 B. Sun, Z. Luo, J. Zhou. Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications. Cardiovasc Diabetol; vol 20, pp 124-131, January 2021.
 B. Kovatchev, C. Cobelli. Glucose variability: timing, risk analysis, and relationship to hypoglycemia in diabetes. Diabetes Care; vol 39, pp 502–510, Octomber 2016.
 T. Battelino, T. Danne, R.M, Bergenstal, S.A. Amiel, R. Beck, T. Biester, et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations from the International Consensus on Time in Range. Diabetes Care, vol 42, pp 1593-1603, June 2019.
 G.E. Umpierrez, B.P. Kovatchev. Glycemic Variability: How to Measure and Its Clinical Implication for Type 2. Diabetes Am J Med Sci 356(6):518-527, 2018.
 N. C. G Kwai, R. Arnold, A.M. Poynten, A.V. Krishnan. Association between glycemic variability and peripheral nerve dysfunction in type 1 diabetes. Muscle Nerve, vol 54, pp 967–969, July 2016.
 M. Akaza, I. Akaza, T. Kanouchi, T. Sasano, Y. Sumi, T. Yokota. Nerve conduction study of the association between glycemic variability and diabetes neuropathy. Diabetol Metab Syndr; vol 10, pp 69, May 2018.
 F. Li, Y. Zhang, H. Li, J. Lu, L. Jiang et al. TIR generated by continuous glucose monitoring is associated with peripheral nerve function in type 2 diabetes. Diabetes Res Clin Pract; vol 166, pp 108-115, February 2020.
 L. Mayeda, R. Katz, I. Ahmad, N. Bansal, Z. Batachhi et al. Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease. BMJ Open Diabetes Res Care; vol 8, pp 84-92, September 2020.
 Y. Hu, L. Zhao, X. Zhang, H. Cai, H. Huang et al. Association of glycaemic variability evaluated by continuous glucose monitoring with diabetic peripheral neuropathy in type 2 diabetic patients. Endocrine; vol 60, pp 292–300, June 2018.
 J. Yang, X. Yang, D. Zhao, X. Wang, W. Wei, H. Yuan. Association of time in range, as assessed by continuous glucose monitoring, with painful diabetic polyneuropathy. J Diabetes Investig; vol12, pp 828– 836, March 2021.
 S. Nyiratz, F. Pesei, A. Orosz, S. Coluzzi, O. Vági et al. Cardiovascular Autonomic Neuropathy and Glucose Variability in Patients with Type 1 Diabetes: Is There an Association? Front Endocrinol; vol 9, pp 174, November 2018.
 J.E. Jun, S.E. Lee, Y.B. Lee, Y.J. Ahn, G. Kim, Y.K. Hur et al. Continuous glucose monitoring de¦ned glucose variability is associated with cardiovascular autonomic neuropathy in type 1 diabetes. Diabetes Metab Res Rev, vol 35, pp 30-38, May 2019.
 S. Kalopita, S. Liatis, P. Thomakos, I.Vlahodimitris, C. Stathi, N. Katsilambros et al. Relationship between autonomic nervous system function and continuous interstitial glucose measurement in patients with type 2 diabetes. J Diabetes Res; vol 22, pp 127-135, Octomber 2014.
 J.E. Jun, S.M. Jin, J. Baek, S. Oh, Y.K. Hur, M.S. Lee, et al. The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes. Cardiovasc Diabetol; vol 4, pp 70, March 2015.
 Y. Kim, G. Kim, J.Y. Park, M.S. Choi, J.E. Jun et al. The Association Between Continuous Glucose Monitoring-derived Metrics, Including Time in Range, and Cardiovascular Autonomic Neuropathy in Outpatients with Type 2 Diabetes. Research Square, vol 17, pp 172-183, May 2020.
 D. Matsutani, M. Sakamoto, H. Iuchi, S. Minato, H. Suzuki et al. Glycemic variability in continuous glucose monitoring is inversely associated with baroreflex sensitivity in type 2 diabetes: a preliminary report. Cardiovasc Diabetol; vol 17, pp 36, July 2018.
 C.A. van Beers, J.H. DeVries, S.J. Kleijer, M.M. Smits, P.H. Geelhoed-Duijvestijn, et al. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial. Lancet Diabetes Endocrinol; vol 4, pp 893-902, September 2016.
 Y.K. Lin, S.J. Fisher, R. Pop-Busui. Hypoglycemia unawareness and autonomic dysfunction in diabetes: Lessons learned and roles of diabetes technologies. J Diabetes Investig; vol 11, pp 1388-1402, January 2020.